Abstract
Background:
Parenchymal hemorrhage is one of the most feared risks of stereotactic brain biopsies
potentially resulting in neurological deficits or even a fatal outcome. Patients with
disorders of the coagulation system are at particular risk, so identifying these is
one of the main tasks prior to surgery. Some patients may have a bleeding tendency
despite normal laboratory values of the hemostatic system.
Case Report:
We report the case of a patient with coagulopathy of unclear etiology undergoing a
stereotactic brainstem biopsy.
Conclusion:
A medication scheme with tranexamic acid and desmopressin effectively decreased the
patient’s bleeding time in vivo and the procedure was carried out without complications.
Key words
intracranial tumor - anaplastic astrocytoma - stereotaxy - presurgical planning -
coagulopathy
